View Full Version : No Added Benefit Proven For Belimumab For Lupus Erythematosus

08-31-2012, 02:12 AM
Belimumab (trade name Benlysta ) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment when the disease is still active in spite of standard therapy...

More... (http://www.medicalnewstoday.com/releases/249678.php)